Plasma thrombosis markers following cerebral infarction in African Americans

Askiel Bruno, Joseph P. McConnell, Stanley N. Cohen, Gretchen E. Tietjen, De Juran Richardson, Philip B. Gorelick, Nils U. Bang

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Our aim was to evaluate plasma thrombosis markers following non-cardioembolic cerebral infarction for possible correlation with recurrent vascular events. We enrolled 88 subjects treated with antiplatelet drugs and followed them for 2 years with plasma fibrinogen, F1.2, TAT, and D-dimer measurements at baseline, 6, 12, and 24 months. Vascular events were cerebral infarction, myocardial infarction, or vascular death. Recurrent vascular events occurred in 13 subjects and did not correlate with any of the markers, at baseline or during follow-up. There were large within-subject fluctuations in fibrinogen, F1.2, and TAT levels and the D-dimer changed between normal and abnormal in 48% of subjects. This pilot study did not detect a trend for a difference in plasma fibrinogen, F1.2, TAT, or D-dimer levels between African Americans with and without recurrent vascular events following cerebral infarction. Large within-subject fluctuations in these marker levels may limit their usefulness as predictors of vascular events in clinical practice.

Original languageEnglish (US)
Pages (from-to)73-77
Number of pages5
JournalThrombosis Research
Issue number1-2
StatePublished - 2005
Externally publishedYes


  • Atherosclerosis
  • Infarction
  • Plasma thrombosis

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Plasma thrombosis markers following cerebral infarction in African Americans'. Together they form a unique fingerprint.

Cite this